Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Juko Sugihara"'
Publikováno v:
Drug Metabolism and Pharmacokinetics. 15:327-337
Publikováno v:
Drug Metabolism and Pharmacokinetics. 15:318-326
Pharmacokinetics in the plasma, tissue distribution and excretion of TA-510, a novel hepatic agent, were investigated after a single oral (30 mg/kg) or intravenous (3 mg/kg) administration of 14C-labeled TA-510 to male rats and dogs. 1. The absorptio
Publikováno v:
CNS Drug Reviews. 4:25-41
Publikováno v:
Drug Metabolism and Pharmacokinetics. 12:475-482
The transfers of 14C-taltirelin into the fetus and milk and sex-related difference were investigated after a single oral administration of 14C-taltirelin at a dose of 3 mg/kg to rats. The blood level after repeat ed oral dosing was also studied. 1. I
Autor:
Kazuhiro Imai, Takeshi Fukushima, Hiroshi Homma, Juko Sugihara, Tomofumi Santa, Hirohiko Kodama, Masayoshi Yoshikawa
Publikováno v:
Proceedings of the Japan Academy, Series B. 73:48-52
After the intravenous administration of 14C-D-aspartic acid (Asp) into Sprague-Dawley rats (male, 7-week-old), the distribution and elimination of radioactivity was investigated by the whole body autoradiography. High radioactivities were detected in
Publikováno v:
Drug Metabolism and Pharmacokinetics. 12:483-490
The transfer, distribution and degradation of taltirelin in the brain were investigated after oral (3 mg/kg) or intravenous (1 mg/kg) administration and injection into cisterna cerebellomedullaris (300 μg/kg) in rats. 1. Taltirelin was hardly degrad
Publikováno v:
Drug Metabolism and Pharmacokinetics. 12:460-474
The absorption, distribution, excretion and metabolism were investigated after a single oral (3 mg/kg) or intravenous (1 mg/kg) administration of 14C-taltirelin to male rats and dogs. 1. The extent of absorption calculated from the ratio of urinary e
Autor:
Yuzo Matsuoka, Takeshi Fukushima, Kiyoshi Kinoshita, Yasuhiko Kodama, Juko Sugihara, Michio Yamamura
Publikováno v:
Biologicalpharmaceutical bulletin. 20(1)
Anti-ataxic effects of TA-0910, a novel thyrotropin-releasing hormone analog, in mice of the ataxic mutant mouse strain Rolling mouse Nagoya (RMN) are sustained beyond its 2-week oral administration period (Kinoshita et al., Eur. J. Pharmacol., 274,
Publikováno v:
Biologicalpharmaceutical bulletin. 20(1)
Thyrotropin-releasing hormone (TRH) and its analog, TA-0910, ameliorate the ataxia of the mutant mouse, rolling mouse Nagoya, by metabolic normalization in the ventral tegmental field (VTF). We here investigated the distribution of cerebral TRH recep
Autor:
Juko Sugihara, Naomasa Taga
Publikováno v:
RADIOISOTOPES. 26:238-244
The colored substances excreted in bile or urine have bee investigated after adminstration of a high dose of SQ-504 to rats. A reddish-violet colored substance and a bluish-violet colored substance were dominant. Their chemical structures were not as